Shree Ganesh Remedies to migrate to BSE Main Board
Shree Ganesh Remedies got the approval from its Board to shift the company listing from BSE SME platform to BSE main board.
Company : Shree Ganesh Remedies Ltd
Board of Directors at Shree Ganesh Remedies in a meeting held on 21st August, 2020, considered the proposal of migration of the company from BSE SME platform to BSE Main Board
In August 2017, Shree Ganesh Remedies issued its 23.76 lacs equity shares at the value of Rs.36 per equity share, aggregating to Rs.8.55 crore.
Currently, trading price of the script of Shree Ganesh Remedies is Rs.117.15 per equity share at the BSE main board (24th Aug, 2020)
Shree Ganesh Remedies Ltd (Headquartered in Ankleshwar, Gujarat) is engaged in manufacturing of drug intermediates and chemicals. The Company manufactures products relating to antipsychotic, antiseptic, deprotonation reactions, hyperlipidemia, alzheimers and anti-viral.
Shree Ganesh Remedies has entered the International market in the year 2006 and are on regular basis exporting their products to various countries.